Cargando…
Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470.
Using the rat tumour cell line LY80, a subline of Yoshida sarcoma, the effects of AGM-1470 on the growth of primary tumour and the incidence of regional lymph node metastasis were evaluated. AGM-1470 (30 mg kg(-1)) was administered subcutaneously or intravenously. Subcutaneous (s.c.) and intravenous...
Autores principales: | Hori, K., Li, H. C., Saito, S., Sato, Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223605/ https://www.ncbi.nlm.nih.gov/pubmed/9192974 |
Ejemplares similares
-
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
por: Kusaka, M., et al.
Publicado: (1994) -
Telomerase Activity Correlates with Growth of Transplantable Osteosarcomas in Rats Treated with cis‐Diammine Dichloroplatinum or the Angiogenesis Inhibitor AGM‐1470
por: Kido, Akira, et al.
Publicado: (1998) -
Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.
por: McLeskey, S. W., et al.
Publicado: (1996) -
BDA AGMs
Publicado: (2023) -
Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer
por: Van den Eynden, G G, et al.
Publicado: (2005)